Lurasidone-d8(1132654-54-6)
- Name: Lurasidone-d8
- Synonyms:Lurasidone-d8;1132654-54-6;(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-Benzothiazol-3-yl)-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione;(3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl-2,2,3,3,5,5,6,6-d8]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione;HY-B0032AS;1ST157185D8;CS-0377660;(1R,2S,6R,7S)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
- Molecular Formula:C28H36N4O2S
- Molecular Weight:500.7
- CAS Registry Number:1132654-54-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1132654-54-6 Lurasidone-d8 hydrochloride
Assay:99%min. Appearance:white powder Package:1kg/Export worthy packing; 25kg/drum Storage:In well-closed container, protected from light and in cool & dry place. Transportation:By Air, By Sea, By courier (door to door, DHL/FedEx/UPS) Application:R&D and production for pharmaceuticals and chemicals
Min. Order:1Gram
Supplier:LIDE PHARMACEUTICALS LIMITED [
China (Mainland)] CAS No.1132654-54-6 Lurasidone-d8
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 1187926-95-9/(S)-2-Hydroxy-3-(3-methoxy-phenyl)-propionic acid ethyl ester
- 1353977-13-5/4-((4-(Methylamino)piperidin-1-yl)methyl)benzonitrile hydrochloride
- 1379324-86-3/6-Bromobenzo[d]isothiazol-3-amine
- 1214832-52-6/2-amino-N-ethyl-3-(1H-indol-3-yl)propanamide
- 1217727-45-1/3-(6-Amino-pyridin-2-yl)-n-boc-l-alanine
- 1214839-01-6/4-(Aminomethyl)hexane-1,4-diol
- 1190310-96-3/5-chloro-3-iodo-7-methyl-1H-pyrrolo[3,2-b]pyridine
- 1025259-81-7/(Z)-2-amino-3-[(4-decoxyphenyl)methylideneamino]but-2-enedinitrile
- 1284226-15-8/Ethyl 2-(trifluoromethyl)indolizine-1-carboxylate
- 1000515-00-3/2-Methyl-3-(trifluoromethyl)phenylacetonitrile
- 1284226-74-9/Imidazo[2,1-b][1,3]benzothiazole-2-carboxylic acid hydrate
- 1353977-72-6/4-((4-Aminopiperidin-1-yl)methyl)benzonitrile hydrochloride
- 1172351-19-7/methyl 2-(3,5-dibromo-4-nitro-1H-pyrazol-1-yl)acetate
- 1284227-02-6/(3R,4S)-rel-4-(3-Fluorophenyl)pyrrolidine-3-carboxylic acid hydrochloride
- 1172352-46-3/N-methyl-2-tosylethanamine hydrochloride
- 1187927-10-1/(3-Oxo-pyrrolidin-1-yl)-acetic acid hydrochloride
- 1063734-01-9/Tert-butyl 3-((cyclopropylmethoxy)methyl)pyrrolidine-1-carboxylate
- 1172356-91-0/2-(3-Fluoro-benzyl)-piperidine hydrochloride
- 1284227-56-0/2-Bromo-4-fluorophenyl chlorothioformate
- 1132654-54-6/Lurasidone-d8
- 1196154-76-3/Tert-butyl 1-methyl-6,7-dihydro-1H-pyrrolo[3,2-C]pyridine-5(4H)-carboxylate
- 1217731-81-1/2-Benzyl-2-azabicyclo[2.2.1]heptane-7-carboxylic acid
- 1227590-95-5/2-Chloromethyl-3-fluoro-6-(trifluoromethyl)pyridine
- 1217732-05-2/(r)-4-(4-Aminomethyl-benzyl)-oxazolidin-2-one
- 1214899-66-7/1-Oxoisoindolin-4-ylboronic acid
- 1187927-21-4/(S)-methyl 3-(1-aminoethyl)benzoate
- 1284228-59-6/(+/-)-trans-4-(3-Chloro-phenyl)-pyrrolidine-3-carboxylic acid-HCl
- 1363339-35-8/2-(4-Bromo-3-fluorophenyl)-5-butyl-1,3-dioxane
- 1310097-13-2/3-Bromo-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9(4H)-one
- 1185110-46-6/2-Acetoxy-2-methyl-1-propanol-d6